Offer - Urjas Oil for just ₹ 1 X
Apnicaf 3 ml Injection (1), a prescription drug, is manufactured in various forms such as Injection. Migraine, Respiratory Distress Syndrome are some of its major therapeutic uses. The alternative uses of Apnicaf 3 ml Injection (1) have also been explained below.
The right dosage of Apnicaf 3 ml Injection (1) depends on the age, gender, and medical history of the patient. Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. Detailed information has been provided in the dosage section.
Apart from the aforementioned side effects, Apnicaf 3 ml Injection (1) can also lead to other problems, which have been listed below. Such side effects of Apnicaf 3 ml Injection (1) normally do not last long and go away once the treatment is completed. Please speak with your doctor if these side effects worsen or persist for a longer duration.
In addition, Apnicaf 3 ml Injection (1)'s effect is Mild during pregnancy and Mild for lactating mothers. In addition, Apnicaf 3 ml Injection (1)'s effects on the liver, heart and kidney are discussed below in the Apnicaf 3 ml Injection (1) related warnings section.
Individuals suffering from medical conditions like Peptic Ulcer, Heart Disease, Liver Disease must refrain from the use of Apnicaf 3 ml Injection (1) since this can cause severe adverse effects. Other conditions have been mentioned below in the Apnicaf 3 ml Injection (1) contraindications section.
Additionally, Apnicaf 3 ml Injection (1) may also adversely react with other medicines. See below for a complete list.
Along with the above-mentioned precautions, remember that taking Apnicaf 3 ml Injection (1) is considered safe while driving, and is addictive.
Apnicaf 3 ml Injection (1) is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Neonates (0 to 1 month) |
|
Is the use of Apnicaf 3 ml Injection (1) safe for pregnant women?
Pregnant women can consume [medicine]. Though Apnicaf has mild side effects when taken during pregnany
Is the use of Apnicaf 3 ml Injection (1) safe during breastfeeding?
Side effects of Apnicaf on breastfeeding women are very mild.
What is the effect of Apnicaf 3 ml Injection (1) on the Kidneys?
Using Apnicaf does not have any harmful effects on kidneys.
What is the effect of Apnicaf 3 ml Injection (1) on the Liver?
Apnicaf does not damage the liver.
What is the effect of Apnicaf 3 ml Injection (1) on the Heart?
Apnicaf is not harmful for the heart.
Apnicaf 3 ml Injection (1) should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
Mild
If you are suffering from any of the following diseases, you should not take Apnicaf 3 ml Injection (1) unless your doctor advises you to do so -
Is this Apnicaf 3 ml Injection (1) habit forming or addictive?
Yes, you can get addicted to Apnicaf 3 ml Injection (1). It is essential that you take [medicine] only after doctor's recommendation.
Is it safe to drive or operate heavy machinery when consuming?
Yes, it is safe to do these activities or work after taking Apnicaf 3 ml Injection (1) as it does not make you drowsy.
Is it safe?
Yes, but consume Apnicaf 3 ml Injection (1) only on doctor's advice.
Is it able to treat mental disorders?
No, Apnicaf 3 ml Injection (1) cannot treat any kind of mental disorder.
Interaction between Food and Apnicaf 3 ml Injection (1)
You can take Apnicaf 3 ml Injection (1) with food.
Interaction between Alcohol and Apnicaf 3 ml Injection (1)
Consuming Apnicaf 3 ml Injection (1) with alcohol can have many serious effects on your body.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 488